Novo Nordisk to Cut 9,000 Jobs as Competition Rises
Novo Nordisk, the company behind Ozempic and Wegovy, will cut 9,000 jobs globally as competition increases and the pharmaceutical industry adapts to new challenges.
Anthropic’s survey of 80,508 Claude users shows people want AI to strip out administrative drag, manage schedules and reclaim time, even as concerns about accuracy and job loss keep adoption cautious.
A draft EU law would require employers to inform workers about algorithmic management systems, ban certain data uses, and ensure human review of major job decisions. The proposal marks a new approach to regulating workplace technology across Europe.
Novo Nordisk, the company behind Ozempic and Wegovy, will cut 9,000 jobs globally as competition increases and the pharmaceutical industry adapts to new challenges.